Stock listing
ACOG Stock Price, News, Filings & Events — Alpha Cognition Inc.
Selected listing: ACOG · BOATS · USD · US
This page tracks Alpha Cognition Inc.'s ACOG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACOG:BOATS. ACOG:BOATS is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.
- Ticker
- ACOG:BOATS
- Asset type
- Stock
- Market cap
- $192.3M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- BOATS
- Currency
- USD
Alpha Cognition Inc. ACOG:BOATS stock context
This page tracks Alpha Cognition Inc.'s ACOG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACOG:BOATS. ACOG:BOATS is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.
Latest news from Alpha Cognition Inc.
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
August 17, 2026
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
August 13, 2026
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
August 3, 2026
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
July 29, 2026
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
July 10, 2026
Alpha Cognition Inc. earnings calls
Alpha Cognition Inc. (ACOG) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Alpha Cognition Inc. (ACOG) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Alpha Cognition Inc. (ACOG) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Alpha Cognition Inc. (ACOG) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Alpha Cognition Inc. (ACOG) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Alpha Cognition Inc. (ACOG) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Alpha Cognition Inc.
Alpha Cognition Inc. investor report
Review AI stock analysis and investor report context for ACOG:BOATS.
Alpha Cognition Inc. company profile
View the public company page for Alpha Cognition Inc. on 6ix.
Alpha Cognition Inc. news
Read company news and market updates connected to Alpha Cognition Inc..
Alpha Cognition Inc. investor events
Find investor webinars, events, and replay context for Alpha Cognition Inc..